KYMR
Kymera Therapeutics Inc
112.00$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | 610.3% | 258.9% | -177.0% | -326.9% | -130.8% | -413.2% | -594.1% | |
| – | 28.1% | 5.2% | 3.3% | 6.4% | 4.5% | 15.7% | 21.2% | |
| – | 40.8% | 15.2% | 34.3% | 75.8% | 54.9% | 116.9% | 152.8% | |
| – | 55.9% | 20.8% | 34.3% | 75.8% | – | – | – | |
| – | 95.2% | 366.9% | -85.0% | -80.3% | 11.8% | -50.9% | 38.9% | |
| – | 18.1% | 26.7% | 2.2% | 6.1% | 43.9% | 27.3% | 3.7% | |
| – | -561.9% | -1,241.7% | -137.1% | 43.8% | 178.0% | -858.4% | -1,329.2% | |
| – | – | 811.8% | 11.0% | 9.2% | – | – | – | |
| – | -12.6% | -1.6% | -1.2% | -2.4% | -0.1% | -3.3% | -3.8% | |
| – | 1,189.9% | 849.9% | 343.6% | 326.7% | 5.3% | 1,293.4% | 2,527.3% | |
| – | 1,238.2% | -132.8% | 29.5% | 43.6% | 52.5% | 21.8% | 604.0% | |
| – | 592.1% | 232.2% | -179.2% | -333.0% | -174.7% | -440.5% | -597.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.